多模式镇痛在冠状动脉旁路移植术中的作用——一项基于人群的分析
这项回顾性队列研究纳入2006年1月至2019年12月全国Premier医疗索赔数据库中349,940例择期冠状动脉旁路移植术成人患者,评估多模式镇痛与术后并发症、住院时间和阿片类药物消耗的关联。多模式镇痛与获益性剂量反应模式相关:随非阿片类镇痛方式增加,并发症风险逐步降低,住院时间逐步缩短。
要点
- 与仅用阿片类药物相比,加用1、2或≥3种非阿片类镇痛方式时,任何并发症的OR分别为0.92、0.83和0.78。
- 呼吸、心脏和肾脏并发症分别分析时,这种逐步降低模式一致。
- 随镇痛方式增加,住院时间逐步缩短。
核心结论
- 这些全国代表性数据表明,通过多条疼痛通路加强疼痛管理与术后并发症显著减少和患者康复时间缩短相关。
研究设计与样本
- 回顾性队列研究,纳入2006年1月至2019年12月全国Premier医疗索赔数据库中349,940例择期冠状动脉旁路移植术成人患者。
- 研究干预为多模式镇痛,定义为阿片类药物联用非阿片类镇痛方式,包括非甾体抗炎药、环氧化酶-2抑制剂、对乙酰氨基酚、椎管内麻醉、类固醇、加巴喷丁/普瑞巴林和氯胺酮。
- 镇痛管理分为4类:仅用阿片类药物,以及多模式镇痛加用1、2或≥3种非阿片类镇痛方式。
- 采用混合效应回归模型评估多模式镇痛与术后并发症、住院时间和阿片类药物消耗(以毫克口服吗啡当量计)的关联。
主要发现
- 多模式镇痛与获益性剂量反应模式相关:加用1、2或≥3种非阿片类镇痛方式时,任何并发症的比值比分别降低8%(OR 0.92;CI 0.90-0.94)、17%(OR 0.83;CI 0.81-0.86)和22%(OR 0.78;CI 0.69-0.79)。
- 这种逐步模式在呼吸、心脏和肾脏并发症分别分析时一致。
- 同样,随镇痛方式增加,住院时间逐步缩短。
关键数值与推荐
- 多模式镇痛定义为阿片类药物联用非阿片类镇痛方式,包括非甾体抗炎药、环氧化酶-2抑制剂、对乙酰氨基酚、椎管内麻醉、类固醇、加巴喷丁/普瑞巴林和氯胺酮。
- 加用1种非阿片类镇痛方式时任何并发症OR 0.92(CI 0.90-0.94)。
- 加用2种非阿片类镇痛方式时任何并发症OR 0.83(CI 0.81-0.86)。
- 加用≥3种非阿片类镇痛方式时任何并发症OR 0.78(CI 0.69-0.79)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Multimodal pain management aims to concurrently target several pain pathways for improved treatment efficacy and recovery. We investigated associations between multimodal analgesia use and postoperative complications, length of hospital stay (LOS), and opioid consumption among patients undergoing coronary artery bypass graft surgery. METHODS: This retrospective cohort study included 349,940 adult patients undergoing elective coronary artery bypass graft surgery (January 2006 to December 2019), from the national Premier Healthcare claims dataset. The study intervention was multimodal analgesia, defined as opioid use with the addition of nonopioid analgesic modalities. These included, nonsteroidal anti-inflammatory drugs, cyclooxygenase-2 inhibitors, paracetamol/acetaminophen, neuraxial anesthesia, steroids, gabapentin/pregabalin, and ketamine. Analgesic management was stratified into 4 categories: opioids only and multimodal analgesia with the addition of 1, 2 or ≥3 nonopioid analgesic modalities. Mixed-effects regression models measured associations between multimodal analgesia and postoperative complications, LOS, and opioid consumption measured in milligram oral morphine equivalents. RESULTS: Multimodal analgesia was associated with a beneficial dose response pattern. With increasing nonopioid analgesic modalities added to opioid analgesia, a stepwise decrease in complication risk was consistently observed, eg, with the addition of 1, 2, or ≥3 nonopioid modalities the odds for any complication decreased by 8% (odds ratio [OR], 0.92; confidence interval [CI], 0.90-0.94), 17% (OR, 0.83; CI, 0.81-0.86), and 22% (OR, 0.78; CI 0.69-0.79), respectively. This stepwise pattern was consistent in respiratory, cardiac, and renal complications individually. Similarly, LOS decreased stepwise with added analgesic modalities. CONCLUSIONS: These nationally representative data indicate that enhanced pain management by multiple pain pathways is associated with significant reductions in postoperative complications and shortened patient recovery.
引用
- Cozowicz C, Zhong H, Poeran J, et al. The impact of multimodal analgesia in coronary artery bypass graft surgery-a population-based analysis. J Thorac Cardiovasc Surg. 2023. PMID: 38042402. doi:10.1016/j.jtcvs.2023.11.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。